IHM
SRPT icon

Iguana Healthcare Management’s Sarepta Therapeutics SRPT Stock Holding History

Iguana Healthcare Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-50,000
Closed -$3.07M – 78
2016
Q3 		$3.07M Buy
+50,000
New +$1.51M 0.55% 53
2016
Q1 		– Sell
-100,000
Closed -$1.75M – 83
2015
Q4 		$3.86M Buy
+100,000
New +$3.24M 1.27% 20
2014
Q1 		– Sell
-70,000
Closed -$1.43M – 92
2013
Q4 		$1.43M Buy
+70,000
New +$2.08M 0.81% 38

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Iguana Healthcare Management's SRPT Position: Q4 2016 in Review

Iguana Healthcare Management sold out of Sarepta Therapeutics (SRPT) in Q4 2016, closing a stake of 50,000 shares — an estimated $3.07M sold.

Iguana Healthcare Management first reported a position in SRPT in Q4 2013 and held it in 3 quarters. The position peaked at $3.86M in Q4 2015. 178 funds tracked by Wall St. Rank hold SRPT as of Q4 2016.

  • Iguana Healthcare Management reported no remaining Sarepta Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Iguana Healthcare Management sold 50,000 Sarepta Therapeutics shares in Q4 2016, an estimated $3.07M.
  • Iguana Healthcare Management first reported a position in Sarepta Therapeutics in Q4 2013 and held it in 3 quarters.
  • Iguana Healthcare Management's Sarepta Therapeutics position peaked at $3.86M in Q4 2015.
  • 178 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2016.

Based on Iguana Healthcare Management's 13F filing for Q4 2016, filed 14 Feb 2017.